/BIAFW
BIAFW Stock - bioAffinity Technologies, Inc.
Healthcare|Medical - Diagnostics & ResearchNASDAQ
$0.33+0.00%
+$0.33 (+0.00%) • Dec 17
62
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.92
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.23
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.36
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for BIAFW
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.33 – $0.33
TARGET (TP)$0.38
STOP LOSS$0.30
RISK/REWARD1:1.7
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta2.42
52W High$0.47
52W Low$0.33
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $9.36M | $2.53M | $4,803 | N/A | N/A |
| Gross Profit | $3.38M | $791,615 | $4,336 | $-4,817 | $-22,242 |
| Gross Margin | 36.1% | 31.3% | 90.3% | N/A | N/A |
| Operating Income | $-8,953,000 | $-7,973,000 | $-4,011,058 | $-2,206,822 | $-2,604,385 |
| Net Income | $-9,040,000 | $-7,937,000 | $-8,154,113 | $-6,326,413 | $-7,268,737 |
| Net Margin | -96.6% | -313.5% | -169771.2% | N/A | N/A |
| EPS | $-22.50 | $-27.30 | $-54.30 | $-25.80 | $-29.70 |
Company Overview
bioAffinity Technologies, Inc. operates as a development-stage company addressing the significant unmet need for non-invasive, early-stage cancer diagnosis and treatment. The firm develops proprietary in-vitro diagnostic tests and targeted cancer therapeutics using breakthrough technology that preferentially targets cancer cells. The company was founded on March 26, 2014 and is headquartered in San Antonio, TX.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
BIAFWBeat Rate
33%
Last 3 quarters
Avg Surprise
+5.6%
EPS vs Estimate
Beats / Misses
1/2
Last 12 quarters
Latest EPS
$-4.74
Q4 2025
EPS Surprise History
Q1 23
No data
Q2 23
No data
Q3 23
No data
Q2 25
-2.3%
$-0.16vs$-0.16
Q3 25
+94.4%
$-0.17vs$-3.00
Q4 25
-75.4%
$-4.74vs$-2.70
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Nov 14, 2025 | $-2.70 | $-4.74 | -75.4% | ✗ MISS |
Q3 2025 | Aug 14, 2025 | $-3.00 | $-0.17 | +94.4% | ✓ BEAT |
Q2 2025 | May 15, 2025 | $-0.16 | $-0.16 | -2.3% | ✗ MISS |
Q3 2023 | Sep 30, 2023 | — | $-0.00 | — | — |
Q2 2023 | Jun 30, 2023 | — | $-0.00 | — | — |
Q1 2023 | Mar 31, 2023 | — | $-0.00 | — | — |
Latest News
Loading news...
Frequently Asked Questions about BIAFW
What is BIAFW's current stock price?
bioAffinity Technologies, Inc. (BIAFW) is currently trading at $0.33 per share. The stock has moved +0.00% today.
What is the analyst price target for BIAFW?
No analyst price targets are currently available for this stock.
What sector is bioAffinity Technologies, Inc. in?
bioAffinity Technologies, Inc. operates in the Healthcare sector, specifically within the Medical - Diagnostics & Research industry. The company is traded on the NASDAQ exchange.
What is BIAFW's market cap?
bioAffinity Technologies, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.
Does BIAFW pay dividends?
No, bioAffinity Technologies, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorBTAI
BioXcel Therapeutics, Inc.
$1.73
Mkt Cap: $0.0B
CCEL
Cryo-Cell International, Inc.
$3.70
Mkt Cap: $0.0B
ECOR
electroCore, Inc.
$4.60
Mkt Cap: $0.0B
NMTC
NeuroOne Medical Technologies Corporation
$0.73
Mkt Cap: $0.0B
NOTV
Inotiv, Inc.
$0.67
Mkt Cap: $0.0B
PRPO
Precipio, Inc.
$22.19
Mkt Cap: $0.0B
RMTI
Rockwell Medical, Inc.
$0.85
Mkt Cap: $0.0B
STRR
Star Equity Holdings, Inc.
$10.95
Mkt Cap: $0.0B
VERU
Veru Inc.
$2.32
Mkt Cap: $0.0B
YI
111, Inc.
$3.69
Mkt Cap: $0.0B
Explore stocks similar to BIAFW for comparison